Home › Products › Infectious Disease › Inbec Tablet 90's
Inbec Tablet 90's
Salt Composition: ABACAVIR,DOLUTEGRAVIR,LAMIVUDINE
- Manufacturer: EMCURE PHARMACEUTICALS LTD
- Pack Size: 90 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 400MG
- Prescription Required
- Storage: Store Inbec Tablet at 25°C Protect the medicine from light and excessive moisture. Keep the medicine out of reach of children and pets If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
₹7424.00₹14926.88
Inclusive of all taxes
Product Introduction
Inbec Tablet contains abacavir, dolutegravir, and lamivudine. It is an antiretroviral medicine that belongs to two drug classes. Abacavir and lamivudine are nucleoside analog reverse transcriptase inhibitors (NRTIs), while dolutegravir is an integrase inhibitor (INI). It is used to treat HIV (human immunodeficiency virus) infection in adults and children over 12 years of age who weigh at least 40 kg. This medicine is not suitable for children under 12 years. Do not take Inbec Tablet if you are allergic to abacavir, dolutegravir, lamivudine, or any other ingredients. Inform your doctor if you are taking fampridine, also known as dalfampridine (used to treat multiple sclerosis). This medicine may cause serious allergic reactions. After taking this medicine, inform your doctor immediately if you experience any skin rash, shortness of breath, facial and foot swelling, chest pain, or cough. Inform your doctor if you have previously had liver disease, hepatitis B or C infection, or kidney problems before starting treatment. Inbec Tablet may increase your risk of heart attack; tell your doctor if you have heart problems, if you smoke, or if you have other conditions that may increase your risk of heart disease, such as high blood pressure or diabetes. Report any symptoms of joint pain, stiffness, and bone problems while taking this medicine.
Uses
HIV infection
How it works
Abacavir inhibits the activity of HIV-1 reverse transcriptase (RT) by competing with the natural substrate dGTP and its incorporation into viral DNA. Dolutegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral DNA integration, which is essential for the HIV replication cycle. In combination, they work by decreasing the amount of HIV in your blood and increasing the number of immune cells that help fight infections in your body. Although Inbec tablet will not cure HIV, these medications may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer.
How to Use
It is an orally available prescription drug. Your doctor will decide the dose and duration of Inbec Tablet based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water. Do not take an antacid during the 6 hours before you take this medicine or at least 2 hours after you take it.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious: Heart attack Hepatitis B reactivation Hypersensitivity allergic reaction Common: Insomnia Headache Fatigue
Expert Tips
Take all of the Inbec Tablet and complete the course of therapy even if you feel better after the first few doses. Your doctor will tell you how much medicine to use. Do not take extra dose or medicine to make up for a missed dose. Inform your doctor if you drink alcohol. Supplements that contain calcium or iron (including multivitamins) may be taken with this medicine if you take them with food. Using this medicine while you are pregnant can harm your unborn baby. Do not use this medicine during the first 12 weeks of your pregnancy. Use an effective form of birth control to keep from getting pregnant. Do not breastfeed. You can spread HIV or AIDS to your baby through your breast milk. Your immune system may get stronger when you start taking HIV medicines. This could cause a hidden infection in your body to become active. Tell your doctor right away if you notice any changes in your health.
References
- Triumeq 50 mg/600 mg/300 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc). www.medicines.org.uk. Published June 2022. Accessed May 16, 2023. https://www.medicines.org.uk/emc/files/pil.3318.pdf
- Abacavir, Dolutegravir, and Lamivudine - Highlights of Prescribing Information; 2014. Accessed May 16, 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205551s000lbl.pdf
- KD Tripathi, Essentials of Medical Pharmacology, Antiviral drugs, 7th edition, 2013, 807-808.
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Antiretroviral agents and treatment of HIV infection, 12th edition, 2011, 1635-1636.
Safety Advice
Pregnancy: unsafe Do not take Inbec Tablet if you are in your first six weeks or pregnancy because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment.
Lungs: Consult your doctor It is unknown whether Inbec Tablet is safe to be administer in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.
Breastfeeding: unsafe Breastfeeding is not recommended in women who are HIV positive and taking Inbec Tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.